Highline Wealth Partners’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.5K Buy
82
+56
+215% +$11.6K ﹤0.01% 401
2026
Q1
$5.49K Buy
26
+1
+4% +$215 ﹤0.01% 699
2025
Q4
$5.14K Buy
25
+8
+47% +$1.51K ﹤0.01% 546
2025
Q3
$2.67K Hold
17
﹤0.01% 796
2025
Q2
$2.86K Hold
17
﹤0.01% 571
2025
Q1
$2.34K Buy
17
+8
+89% +$1.02K ﹤0.01% 605
2024
Q4
$1.06K Buy
+9
New +$1.05K ﹤0.01% 522

Other funds holding CAH

Highline Wealth Partners's CAH Position: Q2 2026 in Review

Highline Wealth Partners increased its Cardinal Health (CAH) stake by 215% in Q2 2026, buying an estimated $11.6K and bringing the position to 82 shares worth $19.5K. The position accounts for ﹤0.01% of the portfolio, ranked #401.

Highline Wealth Partners first reported a position in CAH in Q4 2024 and has held it in 7 quarters since. 1,492 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Highline Wealth Partners held 82 shares of Cardinal Health worth $19.5K as of Q2 2026.
  • Highline Wealth Partners bought 56 Cardinal Health shares in Q2 2026, an estimated $11.6K.
  • Cardinal Health made up ﹤0.01% of Highline Wealth Partners's portfolio in Q2 2026, its #401 holding.
  • Highline Wealth Partners first reported a position in Cardinal Health in Q4 2024 and has held it in 7 quarters since.
  • 1,492 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Highline Wealth Partners's 13F filing for Q2 2026, filed 15 Jul 2026.